COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 757
diet-induced obesity. Proc Natl Acad Sci USA.
2013;110(22):9066-71.
[66] Plovier H, Everard A, Druart C, et al. A purified membrane
protein from Akkermansia muciniphila or the pasteurized
bacterium improves metabolism in obese and diabetic mice. Nat
Med. 2017;23(1):107-13.
[67] Ottman N, Reunanen J, Meijerink M, et al. Pili-like proteins of
Akkermansia muciniphila modulate host immune responses and
gut barrier function. PLoS One. 2017;12(3):e0173004.
[68] Dao MC, Everard A, Aron-Wisnewsky J, et al. Akkermansia
muciniphila and improved metabolic health during a dietary
intervention in obesity: relationship with gut microbiome richness
and ecology. Gut. 2016;65(3):426-36.
[69] Karcher N, Pasolli E, Asnicar F, et al. Analysis of 1321
Eubacterium rectale genomes from metagenomes uncovers
complex phylogeographic population structure and subspecies
functional adaptations. Genome Biol. 2020;21(1):138.
[70] Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium
prausnitzii is an anti-inflammatory commensal bacterium identified
by gut microbiota analysis of Crohn disease patients. Proc Natl
Acad Sci USA. 2008;105(43):16731-6.
[71] Louis P, Flint HJ. Diversity, metabolism and microbial ecology
of butyrate-producing bacteria from the human large intestine.
FEMS Microbiol Lett. 2009;294(1):1-8.
[72] Miquel S, Martín R, Rossi O, et al. Faecalibacterium prausnitzii
and human intestinal health. Curr Opin Microbiol.
2013;16(3):255-61.
[73] Quévrain E, Maubert MA, Michon C, et al. Identification of an
anti-inflammatory protein from Faecalibacterium prausnitzii, a
commensal bacterium deficient in Crohn's disease. Gut.
2016;65(3):415-25.
757
